Drug intelligence / Profile preview

saffron ethanolic extract

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Saffron ethanolic extract is a standardized preparation derived from the stigmas of Crocus sativus L., extracted in ethanol. It contains a complex mixture of bioactive compounds, including crocins, picrocrocin, safranal, flavonoids (notably kaempferol and quercetin derivatives), monoterpenes, and various carotenoids and polyphenols[2][5][8]. Notably, crocins are the main apolar active molecules, while picrocrocin and kaempferol derivatives are the major polar components[8]. The extract has demonstrated antioxidant, anti-inflammatory, anti-atherosclerotic, neuroprotective, antidepressant, anticonvulsant, and anxiolytic effects in preclinical and limited clinical studies[1][3][4][6][7]. Effects are thought to occur via modulation of neurotransmitter systems (serotonergic, dopaminergic, noradrenergic), antioxidant enzyme activity (SOD, GPx), and possible GABA-mimetic activity, with evidence supporting the attenuation of oxidative stress and improvement of cognitive impairment and emotional symptoms[1][3][6]. Main indications under investigation include neurodegenerative disorders (such as mild cognitive impairment, Alzheimer’s disease, and multiple sclerosis models), atherosclerosis, depression, and anxiety, but the extract is not an approved pharmaceutical and is primarily employed as a dietary supplement or experimental therapeutic[4][6][7].

Other names
saffron extractCrocus sativus ethanolic extractsaffron alcohol extract
02

Targets

SERT (Sodium-dependent serotonin transporter)DAT (Dopamine plasma membrane transport protein)

Beyond the preview

Go deeper on saffron ethanolic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on saffron ethanolic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call